Molecular-based diagnosis of Multiple Sclerosis and its progressive stage

OBJECTIVE: Biomarkers aid diagnosis, allow inexpensive screening of therapies and guide selection of patient-specific therapeutic regimens in most internal medicine disciplines. In contrast, neurology lacks validated measurements of the physiological status, or dysfunction(s) of cells of the central...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ann Neurol
Autores principales: Barbour, Christopher, Kosa, Peter, Komori, Mika, Tanigawa, Makoto, Masvekar, Ruturaj, Wu, Tianxia, Johnson, Kory, Douvaras, Panagiotis, Fossati, Valentina, Herbst, Ronald, Wang, Yue, Tan, Keith, Greenwood, Mark, Bielekova, Bibiana
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5743213/
https://ncbi.nlm.nih.gov/pubmed/29059494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25083
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares